Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.

about

Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.Cyp2c44-mediated decrease of 15-HETE exacerbates pulmonary hypertension.

P2860

Q36322517-30138CAE-113C-483E-8EA4-0EEB753829B2 Q51815285-E45A0916-C7C7-42CA-A644-BBFC22870E43

P2860

Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.

Item

http://www.wikidata.org/entity/Q51501927

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Tyrosine kinase inhibitor BIBF ...... r pressure adaptation in rats.

@en

Tyrosine kinase inhibitor BIBF ...... r pressure adaptation in rats.

@nl

type

Item

label

Tyrosine kinase inhibitor BIBF ...... r pressure adaptation in rats.

@en

Tyrosine kinase inhibitor BIBF ...... r pressure adaptation in rats.

@nl

prefLabel

Tyrosine kinase inhibitor BIBF ...... r pressure adaptation in rats.

@en

Tyrosine kinase inhibitor BIBF ...... r pressure adaptation in rats.

@nl

P1476

Tyrosine kinase inhibitor BIBF ...... ar pressure adaptation in rats

@en

P2093

Anton Vonk-Noordegraaf

http://www.w3.org/2001/XMLSchema#string

Frances S de Man

http://www.w3.org/2001/XMLSchema#string

Franziska Elena Herrmann

http://www.w3.org/2001/XMLSchema#string

Harm Jan Bogaard

http://www.w3.org/2001/XMLSchema#string

Ingrid Schalij

http://www.w3.org/2001/XMLSchema#string

Lutz Wollin

http://www.w3.org/2001/XMLSchema#string

Michiel Alexander de Raaf

http://www.w3.org/2001/XMLSchema#string

P2860

Pathobiology of pulmonary arterial hypertension and right ventricular failure

Pathophysiological roles of FGF signaling in the heart

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management

Adult cardiac stem cells are multipotent and support myocardial regeneration

Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes.

Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

Platelet-derived growth factor in idiopathic pulmonary fibrosis.

P304

H604-12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00656.2015

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

311

http://www.w3.org/2001/XMLSchema#string

P50

Christophe Guignabert

P577

2016-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27342880

http://www.w3.org/2001/XMLSchema#string

Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.

about

P2860

P2860

Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698